Expand ACRS Menu
ACRS MENU

ACRS Stock Summary and Trading Ideas (Aclaris Therapeutics | NASDAQ:ACRS)

Charts for Today's Stock Price and Implied Volatility in Aclaris Therapeutics

3-Feb-2023

Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for ACRS by Theoretical Edge and Win Rates

Sentiment

Trading Statistics

Key Ratios

Aclaris Therapeutics (ACRS) Frequently Asked Questions

What does Aclaris Therapeutics do?

Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company that operates in the United States. It focuses on developing novel drug candidates for immuno-inflammatory diseases. The company operates in two segments: therapeutics and contract research. The majority of its revenue comes from the contract research segment, which provides laboratory services. Its drug candidates under development are Zunsemetinib, which is an Oral MK2 Inhibitor; ATI-2138 is an ITJ Inhibitor; and ATI-1777.

What symbol and exchange does Aclaris Therapeutics stock trade?

Aclaris Therapeutics trades on the NASDAQ stock market under the symbol ACRS.

What is Aclaris Therapeutics stock price doing today?

As of February 3, 2023, ACRS stock price declined to $14.05 with 1,790,643 million shares trading.

What is Aclaris Therapeutics's Beta?

ACRS has a beta of 0.46, meaning it tends to be less sensitive to market movements. ACRS has a correlation of 0.02 to the broad based SPY ETF.

How much is Aclaris Therapeutics worth?

ACRS has a market cap of $936.90 million. This is considered a Small Cap stock.

How much money does Aclaris Therapeutics make?

Last quarter Aclaris Therapeutics reported $19 million in Revenue and -$.30 earnings per share. This beat revenue expectation by $17 million and exceeded earnings estimates by $.10.

What is the highest and lowest price Aclaris Therapeutics traded in the last 3 year period?

In the last 3 years, ACRS stock traded as high as $30.38 and as low as $.70.

What are the top ETFs holding Aclaris Therapeutics?

The top ETF exchange traded funds that ACRS belongs to (by Net Assets): VTI, IWM, VXF, IWO, IBB.

Is Aclaris Therapeutics (ACRS) a good investment?

ACRS has outperformed the market in the last year with a return of +29.7%, while the SPY ETF lost -6.3%. However, in the most recent history, ACRS shares have underperformed the stock market with its stock returning -7.7% in the last 3 month period and -15.6% for the last 2 week period, while SPY has returned +11.6% and +4.2%, respectively.

What is the support and resistance for Aclaris Therapeutics (ACRS) stock price?

ACRS support price is $13.66 and resistance is $15.01 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ACRS stock will trade within this expected range on the day.